In muscle biopsies from patients with T2D (daily treatment with insulin prior to surgery), the decrease in the mRNA expression level of BRS-3 compared to the levels of the normal subjects was similar to the decrease detected in the muscle tissue sections from patients with obesity (5). The gene discussed is BRS3; the disease is obesity due to melanocortin 4 receptor deficiency.